rs6892205

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006846.4(SPINK5):​c.800A>G​(p.Gln267Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 1,607,930 control chromosomes in the GnomAD database, including 215,197 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q267H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.51 ( 19668 hom., cov: 31)
Exomes 𝑓: 0.52 ( 195529 hom. )

Consequence

SPINK5
NM_006846.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -3.98

Publications

45 publications found
Variant links:
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
FBXO38-DT (HGNC:55589): (FBXO38 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.1259713E-6).
BP6
Variant 5-148095823-A-G is Benign according to our data. Variant chr5-148095823-A-G is described in ClinVar as [Benign]. Clinvar id is 139256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.595 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK5NM_006846.4 linkc.800A>G p.Gln267Arg missense_variant Exon 10 of 33 ENST00000256084.8 NP_006837.2 Q9NQ38-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK5ENST00000256084.8 linkc.800A>G p.Gln267Arg missense_variant Exon 10 of 33 1 NM_006846.4 ENSP00000256084.7 Q9NQ38-1

Frequencies

GnomAD3 genomes
AF:
0.507
AC:
76829
AN:
151480
Hom.:
19656
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.458
Gnomad AMI
AF:
0.507
Gnomad AMR
AF:
0.605
Gnomad ASJ
AF:
0.449
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.489
Gnomad FIN
AF:
0.533
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.518
Gnomad OTH
AF:
0.521
GnomAD2 exomes
AF:
0.532
AC:
132330
AN:
248824
AF XY:
0.526
show subpopulations
Gnomad AFR exome
AF:
0.459
Gnomad AMR exome
AF:
0.709
Gnomad ASJ exome
AF:
0.457
Gnomad EAS exome
AF:
0.478
Gnomad FIN exome
AF:
0.546
Gnomad NFE exome
AF:
0.513
Gnomad OTH exome
AF:
0.527
GnomAD4 exome
AF:
0.515
AC:
750408
AN:
1456332
Hom.:
195529
Cov.:
35
AF XY:
0.513
AC XY:
372040
AN XY:
724698
show subpopulations
African (AFR)
AF:
0.454
AC:
15097
AN:
33282
American (AMR)
AF:
0.695
AC:
30945
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
11878
AN:
26028
East Asian (EAS)
AF:
0.451
AC:
17850
AN:
39610
South Asian (SAS)
AF:
0.487
AC:
41938
AN:
86146
European-Finnish (FIN)
AF:
0.545
AC:
29052
AN:
53324
Middle Eastern (MID)
AF:
0.519
AC:
2965
AN:
5712
European-Non Finnish (NFE)
AF:
0.515
AC:
569918
AN:
1107590
Other (OTH)
AF:
0.512
AC:
30765
AN:
60084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
18525
37050
55576
74101
92626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16466
32932
49398
65864
82330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.507
AC:
76871
AN:
151598
Hom.:
19668
Cov.:
31
AF XY:
0.510
AC XY:
37743
AN XY:
74066
show subpopulations
African (AFR)
AF:
0.458
AC:
18930
AN:
41376
American (AMR)
AF:
0.605
AC:
9192
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.449
AC:
1558
AN:
3468
East Asian (EAS)
AF:
0.475
AC:
2424
AN:
5106
South Asian (SAS)
AF:
0.491
AC:
2360
AN:
4810
European-Finnish (FIN)
AF:
0.533
AC:
5601
AN:
10518
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.518
AC:
35101
AN:
67824
Other (OTH)
AF:
0.521
AC:
1098
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1925
3850
5774
7699
9624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.513
Hom.:
77598
Bravo
AF:
0.514
TwinsUK
AF:
0.526
AC:
1952
ALSPAC
AF:
0.521
AC:
2008
ESP6500AA
AF:
0.460
AC:
1667
ESP6500EA
AF:
0.508
AC:
4132
ExAC
AF:
0.521
AC:
62900
Asia WGS
AF:
0.533
AC:
1846
AN:
3476
EpiCase
AF:
0.514
EpiControl
AF:
0.524

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Disclaimer: This variant has not undergone full assessment. The following are pr eliminary notes: Frequency -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 85% of patients studied by a panel of primary immunodeficiencies. Number of patients: 75. Only high quality variants are reported. -

Netherton syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Ichthyosis linearis circumflexa Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.86
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0010
DANN
Benign
0.12
DEOGEN2
Benign
0.027
.;.;.;T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.0010
N
LIST_S2
Benign
0.17
T;T;T;T
MetaRNN
Benign
0.0000051
T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.59
N;N;.;N
PhyloP100
-4.0
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.090
N;N;N;N
REVEL
Benign
0.047
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0
B;B;.;B
Vest4
0.019
MPC
0.10
ClinPred
0.0035
T
GERP RS
-7.6
Varity_R
0.051
gMVP
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6892205; hg19: chr5-147475386; COSMIC: COSV56248822; API